NGLY1 Deficiency PerlQuest

Grace Science Logo
“We’ve worked closely with the Perlara team since the company’s formation. We are proud to be a launch partner of PerlQuests and are excited about the drug leads that will emerge. Perlara’s nimble platform allows it to quickly iterate and in turn cut down the time when NGLY1 patients can receive a life-saving treatment.”
Matt Wilsey
President of Grace Science Foundation

Our Progress

We’re wrapping up Stage 3! We identified tool compounds, repurposable drugs as well as novel chemotypes that rescue worm and fly disease models. Human cell validation in progress.

Launch your own PerlQuest

Still have questions about PerlQuests?

Follow other PerlQuests

NPA PerlQuest icon 440x260px
PMM2-CDG PerlQuest icon 440x260px
PMM2-CDG PerlQuest icon 440x260px
PMM2-CDG PerlQuest icon 440x260px
PMM2-CDG PerlQuest icon 440x260px

NGLY1 PerlQuest updates from our Blog

Perlara logo 300x108px

Join our mailing list

Translate »